During February 2024, the CIDG contributed to one review in Issue 2, 2024 of the Cochrane Database of Systematic Reviews, and one publication in Clinical Epidemiology and Global Health 

New review

• Korula P, Alexander H, John JSara, Kirubakaran R, Singh B, Tharyan P, Rupali P. Favipiravir for treating COVID‐19. Cochrane Database of Systematic Reviews 2024, Issue 2. Art. No.: CD015219. DOI: 10.1002/14651858.CD015219.pub2

Other publications

• Singh B, Alexander H, Tharyan P, Mathew JL, Garner P, Rupali P. Covid management guidelines India group. The COVID guidelines India project: a rapid living evidence synthesis during a pandemic in a LMIC setting. Clinical Epidemiology and Global Health, 23 Feb 2024 [Epub ahead of print]: 101548. DOI: 10.1016/j.cegh.2024.101548 

Throughout 2024, we will continue to add publications to our CIDG and READ-It websites regularly.  Do check our websites for regular updates and follow us on  X  

The CIDG editorial base is located at the Liverpool School of Tropical Medicine in Liverpool, UK. Over 600 authors from some 52 countries contribute to the preparation of the Cochrane Reviews. They are supported by an international team of Editors, each with topic or methodological expertise. The CIDG’s main areas of work are on determination of the effects of interventions on the prevention or treatment infectious diseases of relevance to the United Nations Sustainable Development Goals.